NO309475B1 - Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel - Google Patents

Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel Download PDF

Info

Publication number
NO309475B1
NO309475B1 NO972731A NO972731A NO309475B1 NO 309475 B1 NO309475 B1 NO 309475B1 NO 972731 A NO972731 A NO 972731A NO 972731 A NO972731 A NO 972731A NO 309475 B1 NO309475 B1 NO 309475B1
Authority
NO
Norway
Prior art keywords
group
compound
acid
reference example
trans
Prior art date
Application number
NO972731A
Other languages
English (en)
Norwegian (no)
Other versions
NO972731L (no
NO972731D0 (no
Inventor
Sadao Ishihara
Fujio Saito
Yasuo Ohhata
Shigeki Miyake
Ryosuke Yorikane
Norio Fukuda
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO972731D0 publication Critical patent/NO972731D0/no
Publication of NO972731L publication Critical patent/NO972731L/no
Publication of NO309475B1 publication Critical patent/NO309475B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO972731A 1994-12-15 1997-06-13 Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel NO309475B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP31151194 1994-12-15
PCT/JP1995/002545 WO1996018620A1 (fr) 1994-12-15 1995-12-13 Composes thiazolidinone ou medicament pour prevenir ou guerir l'angine de poitrine contenant ces composes en tant qu'ingredient actif

Publications (3)

Publication Number Publication Date
NO972731D0 NO972731D0 (no) 1997-06-13
NO972731L NO972731L (no) 1997-08-14
NO309475B1 true NO309475B1 (no) 2001-02-05

Family

ID=18018119

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972731A NO309475B1 (no) 1994-12-15 1997-06-13 Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel

Country Status (21)

Country Link
US (1) US5843973A (da)
EP (1) EP0798298B1 (da)
KR (1) KR100312471B1 (da)
CN (1) CN1092649C (da)
AT (1) ATE203987T1 (da)
AU (1) AU692334B2 (da)
CA (1) CA2207794A1 (da)
CZ (1) CZ292626B6 (da)
DE (1) DE69522118T2 (da)
DK (1) DK0798298T3 (da)
ES (1) ES2161916T3 (da)
FI (1) FI972510A (da)
GR (1) GR3036704T3 (da)
HK (1) HK1000494A1 (da)
HU (1) HUT77131A (da)
MX (1) MX9704435A (da)
NO (1) NO309475B1 (da)
NZ (1) NZ297095A (da)
PT (1) PT798298E (da)
RU (1) RU2139283C1 (da)
WO (1) WO1996018620A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200524849A (en) * 2003-07-02 2005-08-01 Hoffmann La Roche Hydroxyalkylamide derivatives
EP1692121A1 (en) 2003-11-18 2006-08-23 University of Tennessee Research Foundation Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof
TR201903981T4 (tr) 2008-06-16 2019-04-22 Univ Ohio State Res Found Kanser tedavisi için bileşikler.
US9447049B2 (en) 2010-03-01 2016-09-20 University Of Tennessee Research Foundation Compounds for treatment of cancer
US8822513B2 (en) 2010-03-01 2014-09-02 Gtx, Inc. Compounds for treatment of cancer
US9029408B2 (en) 2008-06-16 2015-05-12 Gtx, Inc. Compounds for treatment of cancer
EP2290114A1 (de) 2009-08-04 2011-03-02 Gebr. Kemper GmbH + Co. KG Metallwerke Wasserführendes Bauteil
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5213910A (en) * 1975-07-19 1977-02-02 Toshinori Kawabuchi Photogravure printing press
GB8717068D0 (en) * 1987-07-20 1987-08-26 Fujisawa Pharmaceutical Co Nitric ester derivative
AU647599B2 (en) * 1991-03-27 1994-03-24 Sankyo Company Limited New thiazolidinone and oxazolidinone derivatives, their preparation and their use as vasodilators
CZ290989B6 (cs) * 1995-03-02 2002-11-13 Sankyo Company, Limited Opticky aktivní thiazolidinonový derivát, prostředek jej obsahující, pouľití tohoto derivátu a způsob jeho přípravy

Also Published As

Publication number Publication date
CN1092649C (zh) 2002-10-16
NO972731L (no) 1997-08-14
DK0798298T3 (da) 2001-10-22
GR3036704T3 (en) 2001-12-31
RU2139283C1 (ru) 1999-10-10
FI972510A (fi) 1997-08-07
EP0798298B1 (en) 2001-08-08
ATE203987T1 (de) 2001-08-15
EP0798298A1 (en) 1997-10-01
US5843973A (en) 1998-12-01
DE69522118D1 (de) 2001-09-13
KR100312471B1 (ko) 2002-02-28
FI972510A0 (fi) 1997-06-13
CZ183497A3 (en) 1997-12-17
CN1175250A (zh) 1998-03-04
DE69522118T2 (de) 2002-04-25
AU692334B2 (en) 1998-06-04
AU4187996A (en) 1996-07-03
PT798298E (pt) 2001-11-30
HK1000494A1 (en) 2002-03-15
EP0798298A4 (en) 1998-03-25
WO1996018620A1 (fr) 1996-06-20
CA2207794A1 (en) 1996-06-20
HUT77131A (hu) 1998-03-02
NO972731D0 (no) 1997-06-13
CZ292626B6 (cs) 2003-11-12
NZ297095A (en) 1998-09-24
ES2161916T3 (es) 2001-12-16
MX9704435A (es) 1997-10-31

Similar Documents

Publication Publication Date Title
USRE33024E (en) Bronchodilating 8-hydroxy-5-(1R)-1-hydroxy-2-(N-((1R)-2-(p-methoxyphenyl)-1-methylethyl)-amino)ethyl) carbostyril and intermediates thereof
JP6832946B2 (ja) キナーゼ阻害剤およびその中間体の調製方法
NZ270083A (en) N-aryl oxazolidin-2-one derivatives and medicaments
NO165192B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
US5621142A (en) Aminoalkylcyclopropane derivatives
JP3565878B2 (ja) シクロペンタン−および−ペンテン−β−アミノ酸
TW202222770A (zh) 苄胺或苄醇衍生物及其用途
NO309475B1 (no) Tiazolidinonforbindelser og terapeutisk eller forhindrende middel mot angina pectoris omfattende forbindelsene som aktiv bestanddel
EP0443498A1 (en) Isoindoline derivatives
JPH07278137A (ja) チオラン誘導体
US6649639B2 (en) Antipicornaviral compounds, compositions containing them, and methods for their use
EP0975588B1 (en) Antipicornaviral compouds, compositions containing them, and methods for their use
CZ2000804A3 (cs) Způsob výroby proteázového inhibitoru
JPS63310882A (ja) ポリ酸素化されたラブダン誘導体及びその製造法
JPH05155834A (ja) アミノ酸誘導体
US5681858A (en) Cycloalkyl hydroxyureas
SK86593A3 (en) Substituted quinol-2-yl-methoxy-phenylacetic acid derivatives
CA3180417A1 (en) Synthesis of (2s,5r)-5-(2-chlorophenyl)-1-(2'-methoxy-[1,1'-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid
CZ233692A3 (en) Quinolin-2-yl-methoxybenzyl hydroxyureas
JPH05294921A (ja) 新規なフェニル置換シクロアルキル尿素誘導体および組成物
JPH01172365A (ja) 光学活性な３−アミノ−４−シクロヘキシル−２−ヒドロキシ酪酸塩酸塩およびその製造方法
US5654461A (en) Sulfamate compound containing carbamoyl group
US6479672B1 (en) Diastereoselective preparation of Michael adducts
PL163378B1 (pl) Sposób wytwarzania nowych pochodnych benzoksazolonu PL PL PL
US20040236118A1 (en) Pyrrolidine derivatives and method of synthesizing these